Latest Articles
-
What’s Happening With CVS Health Stock?
[Updated: Nov 19, 2021] CVS Stock Update The stock price of CVS Health (NYSE: CVS) rose 3% yesterday after the company announced that it will close 900 of its stores, reflecting 9% of its total stores in the U.S. The company will focus on addi...
-
Forecast Of The Day: Number Of Retail Prescriptions Filled By CVS
What? The Number Of Retail Prescriptions Filled By CVS Health (NYSE:CVS) rose from 1.42 billion in 2019 to 1.47 billion in 2020. Trefis expects the metric to rise to around 1.52 billion in 2021 and 1.58 billion in 2022. Why? We expect growth t...
-
What’s Next For CVS Health Stock After Q3 Beat?
[Updated: Nov 8, 2021] CVS Stock Rise The stock price of CVS Health (NYSE: CVS) has seen a rise of 11% over the last month, while it is up 7% over the last ten days. The recent rise can be attributed to its upbeat Q3 results. The company’...
-
What Will We See From CVS Health Stock Post Q3 Results?
CVS Health (NYSE: CVS) is scheduled to report its Q3 2021 results on Wednesday, Nov 3. We expect the company to likely post revenue and earnings marginally above the street expectations, driven by a recovery in its pharmacy management business....
-
This Stock Is Likely A Better Pick Over Walgreens Boots Alliance
We think that CVS Health stock (NYSE: CVS) currently is a better pick compared to Walgreens Boots Alliance stock (NYSE: WBA), despite Walgreens revenue growing at a faster pace over the last twelve month period. CVS trades at about 0.4x trailing...
-
Should You Buy CVS Health Stock At Around $80 Levels?
[Updated: 8/9/2021] CVS Stock Update CVS Health (NYSE: CVS) recently reported its Q2 results, which were better than Trefis’ as well as the street estimates. The company reported sales of $72.6 billion, up 11% y-o-y, and it was comfortab...
-
What To Expect From CVS Health Stock Post Q2 Results?
CVS Health (NYSE: CVS) is scheduled to report its Q2 2021 results on Wednesday, Aug 4. We expect CVS Health to likely post revenue and earnings slightly above the street expectations, primarily driven by Covid-19 vaccine administration. The com...
-
What’s Next For CVS Health Stock After A 16% Rise This Month?
[Updated: 5/19/2021] CVS Update The stock price of CVS Health (NYSE:CVS) has seen a large 16% move so far this month. Earlier in the month, the stock appreciated after the company reported a solid Q1 beat and more recently, CVS stock rallied a...
-
Should You Buy CVS Health Stock After Q1 Beat?
[Updated: 5/5/2021] CVS Stock Rise The stock price of CVS Health (NYSE:CVS) has seen a 6.5% rise over the last five trading days, after the company announced better than expected Q1 results. CVS’ Q1 revenue of $69.1 billion was ahead of the $6...
-
What To Expect From CVS Health’s Q1?
CVS Health (NYSE: CVS) is scheduled to report its Q1 2021 results on Tuesday, May 4. We expect CVS Health to likely post revenue and earnings below the street expectations, as a rebound in total procedure volume may result in higher benefit cos...
-
Can CVS Health Stock Offer More Upside?
The stock price of CVS Health (NYSE: CVS) looks attractive at current levels of $76. The stock is up 49% from the level of $51 it was at on March 23, 2020, when broader markets made a bottom due to the spread of Covid-19. This marks an underperfo...
-
Is CVS Health A Better Pick Over UnitedHealth Stock?
We think that CVS Health (NYSE:CVS) currently is a better pick compared to UnitedHealth Group (NYSE:UNH) . CVS stock trades at about 0.3x trailing revenues, compared to around 1.2x for UNH. Does this gap in CVS Health’s valuation make se...
-
Should You Buy CVS Health Stock At $70?
We believe that CVS Health stock (NYSE: CVS) is a good buying opportunity at the present time. CVS stock trades near $70 currently and it is, in fact, down 6% from its pre-Covid high of $74 in February 2020 – just before the coronavirus pandemic...
-
CVS Health Stock Remains Attractive At $65
CVS Health stock (NYSE: CVS) is down 12% since the start of the year and it has gained around 23% from its March lows. CVS Health could offer an upside in the near term, as the company’s revenues in the last two quarters have grown by 3%. The ong...
-
Cisco, CVS, Merck: Coronavirus Stocks Gone Bad
If you were able to predict earlier this year that dark coronavirus clouds were going to be all over the planet, wouldn’t it make sense to double down on the stocks of the largest drug companies, pharmacy outlets as well as big networking a...
